Last reviewed · How we verify
NCT03483389
Alcohol and Immune Response
NA trial testing Alcohol, Ethyl in Alcohol Drinking in 76 participants. Completed in 18 June 2021.
18 June 2021
Quick facts
| Lead sponsor | Brown University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 76 |
| Start date | 1 October 2018 |
| Primary completion | 18 June 2021 |
| Estimated completion | 18 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Alcohol, Ethyl — full drug profile →
- Alcohol, Ethyl - placebo
Conditions studied
- Alcohol Drinking — all drugs for Alcohol Drinking →
- Alcohol; Harmful Use — all drugs for Alcohol; Harmful Use →
Sponsor
Brown University
Who can join
Adults 21 to 55, any sex, with Alcohol Drinking or Alcohol; Harmful Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates how alcohol affects the immune system and behavior in healthy adults. The study also will examine how an individual's typical drinking habits may affect the immune system's response to alcohol.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acute changes in immune biomarkers under low- and moderate-dose alcohol in light and heavy drinkers: A randomized, placebo-controlled trial.
Monnig MA, Lamb PS, Clark SE, Monti PM. · · 2025 · PMID 40588716 · DOI 10.1111/acer.70106
Verify or expand the search:
- PubMed search for NCT03483389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
Other Brown University trials
Trials by the same sponsor.
- NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
- NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
- NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
- NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
- NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03483389 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brown University
- Last refreshed: 27 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03483389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing